Cargando…
Potential Protection of Pre-Existent Antibodies to Human Coronavirus 229E on COVID-19 Severity
The causes of the broad spectrum of severity in COVID-19 are unknown. A protective effect through humoral immunity from previous infections by viruses of the SARS-CoV-2 family could explain a mild form of this disease. This study aimed to address whether the presence of antibodies against human seas...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430483/ https://www.ncbi.nlm.nih.gov/pubmed/34501647 http://dx.doi.org/10.3390/ijerph18179058 |
_version_ | 1783750713986252800 |
---|---|
author | Guzmán-Martínez, Oscar Guardado, Kathia Varela-Cardoso, Miguel Trujillo-Rivera, Alejandro Gómez-Ñañez, Iván Ortiz-León, María Cristina Espinosa, Rafaela Ramos, Celso Pérez-Carreón, Julio Isael López-Guerrero, Delia Vanesa Sampieri, Clara Luz Alanís-García, Adrián Baruch Rojas-Durán, Fausto Zenteno-Cuevas, Roberto Gutiérrez, Michelle Montero, Hilda |
author_facet | Guzmán-Martínez, Oscar Guardado, Kathia Varela-Cardoso, Miguel Trujillo-Rivera, Alejandro Gómez-Ñañez, Iván Ortiz-León, María Cristina Espinosa, Rafaela Ramos, Celso Pérez-Carreón, Julio Isael López-Guerrero, Delia Vanesa Sampieri, Clara Luz Alanís-García, Adrián Baruch Rojas-Durán, Fausto Zenteno-Cuevas, Roberto Gutiérrez, Michelle Montero, Hilda |
author_sort | Guzmán-Martínez, Oscar |
collection | PubMed |
description | The causes of the broad spectrum of severity in COVID-19 are unknown. A protective effect through humoral immunity from previous infections by viruses of the SARS-CoV-2 family could explain a mild form of this disease. This study aimed to address whether the presence of antibodies against human seasonal coronaviruses (HCoVs) could prevent severe manifestations of COVID-19. A cross-sectional study was carried out in 165 participants. The presence of pre-existent antibodies against the seasonal HCoV-OC43, HCoV-HKU1, HCoV-229E, and HCoV-NL63 were detected. From all of the seasonal HCoVs studied, it was only found that being seropositive to HCoV-229E presented an association (p = 0.012) with developing mild clinical symptoms of COVID-19 or being asymptomatic. Multinomial regression analysis showed that being seropositive to HCoV-229E is associated with mild or moderate clinical symptoms for COVID-19. Statistical analysis also showed that being female is associated with being asymptomatic for SARS-CoV-2 infection or developing mild COVID-19. A subgroup analysis taking only seropositive to HCoV-229E revealed that females are more likely to develop asymptomatic SARS-CoV-2 infection (OR = 27.242, 95% CI 2.092–354.706, p = 0.012). Our results suggest that previous infections by HCoV-229E could prevent more serious clinical manifestations of COVID-19, but these are not the only variables that influence this event. |
format | Online Article Text |
id | pubmed-8430483 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84304832021-09-11 Potential Protection of Pre-Existent Antibodies to Human Coronavirus 229E on COVID-19 Severity Guzmán-Martínez, Oscar Guardado, Kathia Varela-Cardoso, Miguel Trujillo-Rivera, Alejandro Gómez-Ñañez, Iván Ortiz-León, María Cristina Espinosa, Rafaela Ramos, Celso Pérez-Carreón, Julio Isael López-Guerrero, Delia Vanesa Sampieri, Clara Luz Alanís-García, Adrián Baruch Rojas-Durán, Fausto Zenteno-Cuevas, Roberto Gutiérrez, Michelle Montero, Hilda Int J Environ Res Public Health Article The causes of the broad spectrum of severity in COVID-19 are unknown. A protective effect through humoral immunity from previous infections by viruses of the SARS-CoV-2 family could explain a mild form of this disease. This study aimed to address whether the presence of antibodies against human seasonal coronaviruses (HCoVs) could prevent severe manifestations of COVID-19. A cross-sectional study was carried out in 165 participants. The presence of pre-existent antibodies against the seasonal HCoV-OC43, HCoV-HKU1, HCoV-229E, and HCoV-NL63 were detected. From all of the seasonal HCoVs studied, it was only found that being seropositive to HCoV-229E presented an association (p = 0.012) with developing mild clinical symptoms of COVID-19 or being asymptomatic. Multinomial regression analysis showed that being seropositive to HCoV-229E is associated with mild or moderate clinical symptoms for COVID-19. Statistical analysis also showed that being female is associated with being asymptomatic for SARS-CoV-2 infection or developing mild COVID-19. A subgroup analysis taking only seropositive to HCoV-229E revealed that females are more likely to develop asymptomatic SARS-CoV-2 infection (OR = 27.242, 95% CI 2.092–354.706, p = 0.012). Our results suggest that previous infections by HCoV-229E could prevent more serious clinical manifestations of COVID-19, but these are not the only variables that influence this event. MDPI 2021-08-27 /pmc/articles/PMC8430483/ /pubmed/34501647 http://dx.doi.org/10.3390/ijerph18179058 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Guzmán-Martínez, Oscar Guardado, Kathia Varela-Cardoso, Miguel Trujillo-Rivera, Alejandro Gómez-Ñañez, Iván Ortiz-León, María Cristina Espinosa, Rafaela Ramos, Celso Pérez-Carreón, Julio Isael López-Guerrero, Delia Vanesa Sampieri, Clara Luz Alanís-García, Adrián Baruch Rojas-Durán, Fausto Zenteno-Cuevas, Roberto Gutiérrez, Michelle Montero, Hilda Potential Protection of Pre-Existent Antibodies to Human Coronavirus 229E on COVID-19 Severity |
title | Potential Protection of Pre-Existent Antibodies to Human Coronavirus 229E on COVID-19 Severity |
title_full | Potential Protection of Pre-Existent Antibodies to Human Coronavirus 229E on COVID-19 Severity |
title_fullStr | Potential Protection of Pre-Existent Antibodies to Human Coronavirus 229E on COVID-19 Severity |
title_full_unstemmed | Potential Protection of Pre-Existent Antibodies to Human Coronavirus 229E on COVID-19 Severity |
title_short | Potential Protection of Pre-Existent Antibodies to Human Coronavirus 229E on COVID-19 Severity |
title_sort | potential protection of pre-existent antibodies to human coronavirus 229e on covid-19 severity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430483/ https://www.ncbi.nlm.nih.gov/pubmed/34501647 http://dx.doi.org/10.3390/ijerph18179058 |
work_keys_str_mv | AT guzmanmartinezoscar potentialprotectionofpreexistentantibodiestohumancoronavirus229eoncovid19severity AT guardadokathia potentialprotectionofpreexistentantibodiestohumancoronavirus229eoncovid19severity AT varelacardosomiguel potentialprotectionofpreexistentantibodiestohumancoronavirus229eoncovid19severity AT trujilloriveraalejandro potentialprotectionofpreexistentantibodiestohumancoronavirus229eoncovid19severity AT gomeznanezivan potentialprotectionofpreexistentantibodiestohumancoronavirus229eoncovid19severity AT ortizleonmariacristina potentialprotectionofpreexistentantibodiestohumancoronavirus229eoncovid19severity AT espinosarafaela potentialprotectionofpreexistentantibodiestohumancoronavirus229eoncovid19severity AT ramoscelso potentialprotectionofpreexistentantibodiestohumancoronavirus229eoncovid19severity AT perezcarreonjulioisael potentialprotectionofpreexistentantibodiestohumancoronavirus229eoncovid19severity AT lopezguerrerodeliavanesa potentialprotectionofpreexistentantibodiestohumancoronavirus229eoncovid19severity AT sampiericlaraluz potentialprotectionofpreexistentantibodiestohumancoronavirus229eoncovid19severity AT alanisgarciaadrianbaruch potentialprotectionofpreexistentantibodiestohumancoronavirus229eoncovid19severity AT rojasduranfausto potentialprotectionofpreexistentantibodiestohumancoronavirus229eoncovid19severity AT zentenocuevasroberto potentialprotectionofpreexistentantibodiestohumancoronavirus229eoncovid19severity AT gutierrezmichelle potentialprotectionofpreexistentantibodiestohumancoronavirus229eoncovid19severity AT monterohilda potentialprotectionofpreexistentantibodiestohumancoronavirus229eoncovid19severity |